Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis.

Tjokrowidjaja A, Lee CK, Houssami N, Lord S.

Intern Med J. 2014 Aug;44(8):764-70. doi: 10.1111/imj.12481.

PMID:
24863750
2.

Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis.

Lord SJ, Marinovich ML, Patterson JA, Wilcken N, Kiely BE, Gebski V, Crossing S, Roder DM, Gattellari M, Houssami N.

Med J Aust. 2012 Jun 18;196(11):688-92.

PMID:
22708766
3.

Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database: Matched-Pair Analysis of Patients With Female Breast Cancer.

Choi MY, Lee SK, Lee JE, Park HS, Lim ST, Jung Y, Ko BK, Nam SJ; Korean Breast Cancer Society.

Medicine (Baltimore). 2016 Apr;95(16):e3299. doi: 10.1097/MD.0000000000003299.

4.

Male breast cancer in the veterans affairs population: a comparative analysis.

Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R.

Cancer. 2007 Apr 15;109(8):1471-7.

5.

Prognostic factors for male breast cancer: similarity to female counterparts.

Yu E, Stitt L, Vujovic O, Joseph K, Assouline A, Au J, Younus J, Perera F, Tai P.

Anticancer Res. 2013 May;33(5):2227-31.

PMID:
23645780
6.

Locally advanced and metastatic breast cancer in a tertiary hospital.

Tan EY, Wong HB, Ang BK, Chan MY.

Ann Acad Med Singapore. 2005 Nov;34(10):595-601.

7.
8.

Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study.

Marshall EM, Bertaut A, Desmoulins I, Darut-Jouve A, Ponnelle T, Poillot ML, Beltjens F, Arveux P.

Breast J. 2017 Mar;23(2):138-145. doi: 10.1111/tbj.12717. Epub 2016 Dec 9.

PMID:
27935232
9.

Outcome of non-metastatic male breast cancer: 118 patients.

Arslan UY, Oksüzoğlu B, Ozdemir N, Aksoy S, Alkış N, Gök A, Kaplan MA, Gümüş M, Berk V, Uncu D, Baykara M, Colak D, Uyetürk U, Türker I, Işıkdoğan A.

Med Oncol. 2012 Jun;29(2):554-60. doi: 10.1007/s12032-011-9978-9. Epub 2011 May 15.

PMID:
21573973
10.

Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system?

Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, Jackson S, Hortobagyi GN, Fritsche H, Cristofanilli M.

Cancer. 2008 Nov 1;113(9):2422-30. doi: 10.1002/cncr.23852.

11.

Age related influence of triple receptor status on metastatic breast cancer post relapse survival.

Todorovic-Rakovic N, Neskovic-Konstantinovic Z.

J BUON. 2013 Oct-Dec;18(4):851-8.

PMID:
24344008
13.

[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].

Zhang P, Xu BH, Ma F, Li Q, Yuan P, Wang JY, Zhang P.

Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4. Chinese.

PMID:
21875471
14.

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer.

Chia SK, Speers CH, D'yachkova Y, Kang A, Malfair-Taylor S, Barnett J, Coldman A, Gelmon KA, O'reilly SE, Olivotto IA.

Cancer. 2007 Sep 1;110(5):973-9.

15.

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors.

Berghoff AS, Bago-Horvath Z, Ilhan-Mutlu A, Magerle M, Dieckmann K, Marosi C, Birner P, Widhalm G, Steger GG, Zielinski CC, Bartsch R, Preusser M.

Br J Cancer. 2012 Oct 23;107(9):1454-8. doi: 10.1038/bjc.2012.440. Epub 2012 Oct 9.

16.

Is age at diagnosis an independent prognostic factor for survival following breast cancer?

Jayasinghe UW, Taylor R, Boyages J.

ANZ J Surg. 2005 Sep;75(9):762-7.

PMID:
16173989
17.

Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden.

Foukakis T, Fornander T, Lekberg T, Hellborg H, Adolfsson J, Bergh J.

Breast Cancer Res Treat. 2011 Nov;130(2):553-60. doi: 10.1007/s10549-011-1594-z. Epub 2011 May 27.

PMID:
21617918
18.

Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.

Nelson RA, Guye ML, Luu T, Lai LL.

Ann Surg Oncol. 2015 Jan;22(1):24-31. doi: 10.1245/s10434-014-3890-4. Epub 2014 Jul 11.

PMID:
25012264
19.

Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.

Taylor R, Page A, Bampton D, Estoesta J, Rickard M.

J Med Screen. 2004;11(4):199-206.

PMID:
15563775
20.

The influence of young age on outcome in early stage breast cancer.

Fowble BL, Schultz DJ, Overmoyer B, Solin LJ, Fox K, Jardines L, Orel S, Glick JH.

Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):23-33.

PMID:
8083119

Supplemental Content

Support Center